Statins should NOT have been approved for use; Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
Statins ‘should never have been approved for use,’ says cardiologist, Peter Langsjoen, MD
“Statins are being used so aggressively and in such large numbers of people that the adverse effects are now becoming obvious.
“These drugs should never have been approved for use.
“The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of a recent review paper of more than 20 studies done with statins, was quoted as saying in the UK newspaper The Daily Express.
Their review of more than 20 statin studies found evidence that statins can “cause, or worsen, heart failure”, and that there is overwhelming evidence that these drugs accelerate hardening of the arteries.
Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.
Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’
“This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.
The authors of the paper said that many earlier statin studies, prior to 2004, are not reliable.
They noted that starting in 2004, new European regulations insisted on all trial findings, both negative and positive, being declared.
Reference
Johnston L. Statins CAN cause heart disease - Shock research warns drug risks hardened arteries. The Daily Express, 2016 Jan 10;
Reference to the review paper the article is talking about
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Statins permanently damage heart muscle, Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
Statin-induced impairment in heart muscle function appears to be permanent
“Statin-induced impairment in heart muscle function appears to be permanent, and even though patients may clinically benefit from discontinuation of the statin along with supplemental CoQ10, we believe that many years of statin drug therapy result in the gradual accumulation of mitochondrial DNA damage,” according to a 2015 review paper by Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, Peter H. Langsjoen MD, a cardiologist from Texas, and others who reviewed more than 20 statin drug studies done after 2004.
“A prolonged decrease in mitochondrial CoQ10 would diminish the ability to protect mitochondrial DNA from free radical damage.”
Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.
Peter Langsjoen, MD: ‘These drugs [statins] should never have been approved for use.’
“These drugs [statins] should never have been approved for use.
“The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of this 2015 review paper, was quoted as saying in the UK newspaper The Daily Express.
Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’
“This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.
Reference
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Statins CAUSE heart disease and heart failure! Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
‘I cannot find any evidence to support people taking statins,’ says Prof. Harumi Okuyama
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of a recent review of more than 20 studies done with statins, was quoted as saying in the UK newspaper The Daily Express.
The authors of the paper said that many earlier statin studies, prior to 2004, are not reliable.
They noted that starting in 2004, new European regulations insisted on all trial findings, both negative and positive, being declared.
Reference
Johnston L. Statins CAN cause heart disease - Shock research warns drug risks hardened arteries. The Daily Express, 2016 Jan 10;
Reference to the review paper the article is talking about
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Statin studies show NO benefit! Prof. Harumi Okuyama & Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
Statins provide no beneficial effect on coronary heart disease in trials since 2004-2005
“After 2004–2005 [when new penalties were put in place regarding clinical trials in the EU], all clinical trials, performed by scientists relatively free of conflict of interest with pharmaceutical industries, reported… no significant beneficial effects were observed [with the use of statins] for the prevention of CHD [coronary heart disease],” according to a 2015 review paper by Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, Peter H. Langsjoen MD, a cardiologist from Texas, and others who reviewed more than 20 statin drug studies done after 2004.
“Currently, the majority of scientists continue to claim that statins are effective in preventing CHD [coronary heart disease], but these claims are based on meta-analyses of reports, including those published before the EU regulation (mostly in 1990s) [which are unreliable].”
Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.
Peter Langsjoen, MD: ‘These drugs [statins] should never have been approved for use.’
“These drugs [statins] should never have been approved for use.
“The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of this 2015 review paper, was quoted as saying in the UK newspaper The Daily Express.
Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’
“This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.
Reference
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Statins can CAUSE coronary heart disease! Prof. Harumi Okuyama & Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
Statins are NOT effective, but instead can cause hardening of the arteries, heart failure, diabetes
“In summary, statins are not only ineffective in preventing CHD [coronary heart disease] events but instead are capable of increasing [coronary heart disease] and heart failure,” according to a 2015 review paper by Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, Peter H. Langsjoen MD, a cardiologist from Texas, and others who reviewed more than 20 statin drug studies done after 2004.
“Physicians who are involved in prescribing cholesterol-lowering medications cannot ignore the moral responsibility of ‘informed consent’.
“Patients must be informed of all statin adverse effects, including the ability to cause [coronary heart disease] and heart failure, onset of diabetes mellitus, carcinogenicity, teratogenicity [drugs that may cause birth defects] and central and peripheral nervous disorders besides the well-known rhabdomyolysis [a breakdown of muscle tissue that releases a damaging protein into the blood which can damage the kidneys] and hepatic [liver] injury.”
“Most of these adverse effects of statins become apparent after 6 or more years of statin therapy.”
“Chronic administration could ultimately lead to these statin adverse effects as pharmaceutical and biochemical research has now demonstrated.”
Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.
Peter Langsjoen, MD: ‘These drugs [statins] should never have been approved for use.’
“These drugs [statins] should never have been approved for use.
“The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of this 2015 review paper, was quoted as saying in the UK newspaper The Daily Express.
Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’
“This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.
Reference
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Statins contributing to heart failure epidemic; Peter Langsjoen MD
Hi, this is Larry Hobbs @ FatNews.com.
Statins are likely a major contributing factor to the one million heart failures in US each year
“With more than one million heart failure hospitalizations every year in the USA, the rapidly increasing prevalence of congestive heart failure is now described as an epidemic and it is likely that statin drug therapy is a major contributing factor,” according to a 2015 review paper by Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, Peter H. Langsjoen MD, a cardiologist from Texas, and others who reviewed more than 20 statin drug studies done after 2004.
Prof. Harumi Okuyama: ‘I cannot find any evidence to support people taking statins and patients who are on them should stop’
“We have collected a wealth of information on cholesterol and statins from many published papers and find overwhelming evidence that these drugs accelerate hardening of the arteries and can cause, or worsen, heart failure.
“I cannot find any evidence to support people taking statins and patients who are on them should stop,” Prof. Harumi Okuyama from Nagoya City University in Nagoya, Japan, lead author of the 2015 review paper of statin trials, was quoted as saying in the UK newspaper The Daily Express.
Peter Langsjoen, MD: ‘These drugs [statins] should never have been approved for use.’
“These drugs [statins] should never have been approved for use.
“The long-term effects are devastating,” Peter Langsjoen, MD, a cardiologist from Texas and coauthor of this 2015 review paper, was quoted as saying in the UK newspaper The Daily Express.
Dr. Malcolm Kendrick: ‘The harms [of statins] clearly outweigh any previously suggested benefits’
“This study demolishes the argument that these drugs should be prescribed to anyone, as the harms clearly outweigh any previously suggested benefits,” Dr. Malcolm Kendrick, author of The Great Cholesterol Con who has studied cardiovascular disease and statins for many years, was quoted as saying in the UK newspaper The Daily Express.
Reference
Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, and Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol, 2015 Feb 6; 1-11.
Author’s Contact Info
Harumi Okuyama
Nagoya City University and
Institute for Consumer Science and Human Life
Kinjo Gakuin University
2-1723 Omori, Moriyama
Nagoya 463-8521, Japan
Tel.: +81 528 763 840
Fax: +81 528 763 840
okuyamah@kinjo-u.ac.jp
Peter H. Langsjoen MD
East Texas Medical Center
1107 Doctors Drive
Tyler, TX 75701
(903) 595-3778 phone
(903) 595-4962 fax
peterlangsjoen@cs.com
___
cholesterol lowering drugs
Advicor Lovastatin with Niacin
Altocor Lovastatin
Altoprev Lovastatin
Atorlip Atorvastatin
Baycol Cerivastatin (withdrawn 2001)
Caduet Atorvastatin
with Amlodipine (Norvasc)
Canef Fluvastatin
Crestor Rosuvastatin
Inegy Simvastatin
with Ezetimibe (Zetia)
Lescol Fluvastatin
Lipex Simvastatin
Lipitor Atorvastatin
Lipobay Cerivastatin (withdrawn 2001)
Lipostat Pravastatin
Lipvas Atorvastatin
Livalo Pitavastatin
Mevacor Lovastatin
Pitava Pitavastatin
Pravachol Pravastatin
Selektine Pravastatin
Simcard Simvastatin
Simcor Simvastatin with Niacin
Simlup Simvastatin
Sortis Atorvastatin
Torvacard Atorvastatin
Torvast Atorvastatin
Totalip Atorvastatin
Tulip Atorvastatin
Vytorin
Simvastatin
with Ezetimibe (Zetia)
Zocor Simvastatin
Dr Peter Langsjoen discusses Statin-Induced CoQ10 Depletion. IAOMT Tulsa 2012
Dr Peter Langsjoen discusses Statin-Induced CoQ10 Depletion.